HAIM
LLY icon

Hunter Associates Investment Management’s Eli Lilly LLY Stock Holding History

Hunter Associates Investment Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.22M Sell
6,021
-563
-9% -$575K 0.83% 25
2026
Q1 		$6.06M Sell
6,584
-767
-10% -$778K 0.8% 25
2025
Q4 		$7.9M Sell
7,351
-471
-6% -$450K 1.06% 19
2025
Q3 		$5.97M Buy
7,822
+259
+3% +$193K 0.83% 26
2025
Q2 		$5.9M Sell
7,563
-451
-6% -$350K 0.87% 24
2025
Q1 		$6.62M Sell
8,014
-802
-9% -$667K 1.02% 26
2024
Q4 		$6.81M Sell
8,816
-5
-0.1% -$4.14K 1.04% 23
2024
Q3 		$7.82M Sell
8,821
-75
-0.8% -$67.4K 1.21% 20
2024
Q2 		$8.05M Sell
8,896
-1,130
-11% -$904K 1.35% 15
2024
Q1 		$7.8M Hold
10,026
– – 1.31% 19
2023
Q4 		$5.84M Sell
10,026
-143
-1% -$83.5K 1.07% 23
2023
Q3 		$5.46M Buy
10,169
+69
+0.7% +$35.6K 1.11% 24
2023
Q2 		$4.74M Buy
10,100
+454
+5% +$190K 0.93% 27
2023
Q1 		$3.31M Hold
9,646
– – 0.71% 37
2022
Q4 		$3.53M Buy
9,646
+150
+2% +$53.2K 0.85% 31
2022
Q3 		$3.07M Buy
9,496
+180
+2% +$57K 0.79% 32
2022
Q2 		$3.02M Sell
9,316
-9,112
-49% -$2.74M 0.75% 37
2022
Q1 		$5.28M Hold
18,428
– – 1.7% 16
2021
Q4 		$5.09M Sell
18,428
-1,728
-9% -$438K 1.46% 17
2021
Q3 		$4.66M Hold
20,156
– – 1.5% 17
2021
Q2 		$4.63M Buy
20,156
+8,833
+78% +$1.77M 1.44% 18
2021
Q1 		$2.12M Buy
11,323
+343
+3% +$67.1K 0.49% 52
2020
Q4 		$1.85M Sell
10,980
-1,100
-9% -$164K 0.46% 56
2020
Q3 		$1.79M Buy
12,080
+60
+0.5% +$9.29K 0.5% 52
2020
Q2 		$1.97M Hold
12,020
– – 0.59% 43
2020
Q1 		$1.67M Buy
12,020
+7
+0.1% +$962 0.65% 42
2019
Q4 		$1.58M Buy
12,013
+1,100
+10% +$128K 0.49% 52
2019
Q3 		$1.22M Hold
10,913
– – 0.42% 58
2019
Q2 		$1.21M Hold
10,913
– – 0.42% 57
2019
Q1 		$1.42M Sell
10,913
-100
-0.9% -$12.2K 0.5% 55
2018
Q4 		$1.27M Hold
11,013
– – 0.52% 53
2018
Q3 		$1.18M Hold
11,013
– – 0.41% 59
2018
Q2 		$940K Hold
11,013
– – 0.34% 66
2018
Q1 		$852K Buy
11,013
+110
+1% +$8.86K 0.32% 70
2017
Q4 		$921K Hold
10,903
– – 0.34% 65
2017
Q3 		$933K Hold
10,903
– – 0.36% 62
2017
Q2 		$897K Hold
10,903
– – 0.36% 60
2017
Q1 		$917K Sell
10,903
-225
-2% -$18K 0.39% 61
2016
Q4 		$818K Hold
11,128
– – 0.35% 65
2016
Q3 		$893K Hold
11,128
– – 0.38% 64
2016
Q2 		$876K Hold
11,128
– – 0.38% 68
2016
Q1 		$801K Hold
11,128
– – 0.37% 68
2015
Q4 		$938K Sell
11,128
-450
-4% -$37.3K 0.41% 57
2015
Q3 		$969K Hold
11,578
– – 0.45% 50
2015
Q2 		$967K Sell
11,578
-250
-2% -$19K 0.4% 60
2015
Q1 		$859K Hold
11,828
– – 0.34% 70
2014
Q4 		$816K Hold
11,828
– – 0.31% 71
2014
Q3 		$767K Hold
11,828
– – 0.3% 73
2014
Q2 		$735K Hold
11,828
– – 0.29% 80
2014
Q1 		$696K Sell
11,828
-139
-1% -$7.76K 0.27% 84
2013
Q4 		$610K Hold
11,967
– – 0.23% 87
2013
Q3 		$602K Buy
11,967
+39
+0.3% +$2.04K 0.25% 85
2013
Q2 		$586K Buy
+11,928
New +$649K 0.22% 96

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Hunter Associates Investment Management's LLY Position: Q2 2026 in Review

Hunter Associates Investment Management reduced its Eli Lilly (LLY) stake by 8.6% in Q2 2026, selling an estimated $575K and leaving 6,021 shares worth $7.22M. The position accounts for 0.83% of the portfolio, ranked #25.

Hunter Associates Investment Management first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.05M in Q2 2024. 1,691 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Hunter Associates Investment Management held 6,021 shares of Eli Lilly worth $7.22M as of Q2 2026.
  • Hunter Associates Investment Management sold 563 Eli Lilly shares in Q2 2026, an estimated $575K.
  • Eli Lilly made up 0.83% of Hunter Associates Investment Management's portfolio in Q2 2026, its #25 holding.
  • Hunter Associates Investment Management first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • Hunter Associates Investment Management's Eli Lilly position peaked at $8.05M in Q2 2024.
  • 1,691 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Hunter Associates Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.